Sign in
Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies
David M. Brown, MD
Annual Meeting Talks
2021
Retinal Physician Practice Patterns in the Setting of Anticoagulation
Allen Chiang, MD, FASRS
On Demand Cases, Courses, and Papers
2017
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
2019
Category: AMD-Neovascular